Article Details
Retrieved on: 2018-05-26 19:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Melinta Therapeutics (NASDAQ:MLNT) was upgraded by <b>stock</b> analysts at WBB <b>Securities</b> from a “hold” rating to a “buy” rating in a research report ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here